Document Detail


Effect of a cysteine prodrug, L-2-oxothiazolidine-4-carboxylic acid, on the metabolism and toxicity of bromobenzene: an acute study.
MedLine Citation:
PMID:  3621045     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of a cysteine prodrug, L-2-oxothiazolidine-4-carboxylic acid (OTCA), on certain aspects of the metabolism and toxicity of bromobenzene administered acutely to mice was investigated by (i) characterizing the influence of OTCA on the metabolic profile of low and high bromobenzene dose at 0-6, 6-12, and 12-24 h, (ii) determining the effective doses range and administration time for OTCA, as well as the optimum period for urine sampling; and (iii) measuring the efficacy of OTCA for protection against bromobenzene induced toxicity. Coadministration of OTCA and bromobenzene enhanced the urinary excretion of mercapturic acid and phenolic metabolites, during 6-12 h, by approximately 152 and 193%, respectively. Maximum efficacy was observed when OTCA (16.0 mmol/kg) was administered concomitantly with bromobenzene (4.0 mmol/kg). Finally, OTCA administration was found to afford substantial protection against elevation of plasma transaminases used as indices of bromobenzene-induced hepatotoxicity. N-acetylcysteine, another cysteine prodrug, had essentially similar effects on the metabolism and toxicity of bromobenzene. Thus, administration of cysteine prodrugs enhances the urinary excretion of several metabolites of bromobenzene and affords protection against bromobenzene-induced hepatotoxicity.
Authors:
J Brodeur; R Goyal
Related Documents :
3775265 - Influence of oral intake of seven different antibiotics on faecal short-chain fatty aci...
8286715 - Impaired urinary ammonium excretion in patients with isolated proximal renal tubular ac...
3150845 - Potential radiopharmaceuticals for the diagnosis of biliary atresia and neonatal hepati...
22883745 - Anemia secondary to valproic acid therapy in a 13-year-old boy: a case report.
639305 - Adsorption of heparin on sodium acid urate.
9765795 - Response of brucella suis 1330 and b. canis rm6/66 to growth at acid ph and induction o...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Canadian journal of physiology and pharmacology     Volume:  65     ISSN:  0008-4212     ISO Abbreviation:  Can. J. Physiol. Pharmacol.     Publication Date:  1987 May 
Date Detail:
Created Date:  1987-09-30     Completed Date:  1987-09-30     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0372712     Medline TA:  Can J Physiol Pharmacol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  816-22     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcysteine / pharmacology*,  urine
Animals
Bromobenzenes / antagonists & inhibitors*,  metabolism
Drug-Induced Liver Injury
Liver Diseases / prevention & control*
Male
Mice
Phenols / urine
Sulfates / urine
Transaminases / blood
Chemical
Reg. No./Substance:
0/Bromobenzenes; 0/Phenols; 0/Sulfates; 108-86-1/bromobenzene; 616-91-1/Acetylcysteine; EC 2.6.1.-/Transaminases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mechanism of hypocalcemia induced by intraperitoneal, intragastric, and intravenous administration o...
Next Document:  Dose-dependent effects of phencyclidine on hippocampal CA1 neurons.